Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chair and CEO

Chief Operating Officer

Chief Medical Officer

General Counsel, Senior VP

Chief People Strategy Officer

Chief Financial Officer

Chief Commercial Officer

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis, cystic fibrosis, and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey.

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-02-28	Premium	gifted	Premium	Premium	Premium	-
2024-02-28	Premium	gifted	Premium	Premium	Premium	-
2024-02-28	Premium	acquired	Premium	Premium	Premium	Chair and CEO
2024-01-12	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2024-01-12	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-01-10	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2024-01-10	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-01-09	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-01-09	Premium	sold	Premium	Premium	Premium	General Counsel, Senior VP
2024-01-09	Premium	acquired	Premium	Premium	Premium	Chief People Strategy Officer
2024-01-09	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2024-01-09	Premium	sold	Premium	Premium	Premium	Chair and CEO
2024-01-09	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2024-01-09	Premium	sold	Premium	Premium	Premium	Chief People Strategy Officer
2024-01-09	Premium	sold	Premium	Premium	Premium	Chief Commercial Officer
2024-01-08	Premium	sold	Premium	Premium	Premium	Chair and CEO
2024-01-08	Premium	acquired	Premium	Premium	Premium	Chair and CEO
2024-01-05	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2024-01-05	Premium	sold	Premium	Premium	Premium	General Counsel, Senior VP
2024-01-05	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-01-05	Premium	sold	Premium	Premium	Premium	Chief Commercial Officer
2024-01-05	Premium	sold	Premium	Premium	Premium	Chief People Strategy Officer
2024-01-05	Premium	sold	Premium	Premium	Premium	Chair and CEO

INSM - Insmed Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for INSM